[ad_1] Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company specializing in the development of new drugs for the nervous system, has published an article on the transplantation of NSI-532.IGF1 in the scientific journal …
Read More »
[ad_1] Germain Town, Maryland – (와이어) October 26, 2018 – Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company specializing in the development of new drugs for the treatment of the nervous system, Related …
Read More »
[ad_1] ▲ The only flu vaccine from cell cultures in Korea, "Skysell Flu". Photo courtesy = SK Bioscience Influenza A (flu), an acute viral infection that spreads easily to all ages, affects …
Read More »
[ad_1] The Japanese Ministry of Health, Labor and Welfare approved the world's first clinical trial of Parkinson's disease using induced pluripotent stem cells (IPS). IPS cells are stem cells that inject specific …
Read More »
[ad_1] Contrast with Korea, which took a stand on bioethics Japan is pacing in the field of regenerative medicine. Approved a clinical trial of Parkinson's disease using inducible pluripotent stem cells (iPS …
Read More »
[ad_1] Prof. Song Ji-hwan of the Department of Biological Sciences, Daehan University of Science, produced Induced Pluripotent Stem Cells (iPSCs), which could theoretically be transplanted in 41.7% of Koreans without immune rejection …
Read More »
[ad_1] The process by which immune cells that protect our bodies against disease rather favor the metastasis of cancer cells has been specifically identified. The Korea Research Foundation is a professor of …
Read More »
[ad_1] [뉴스토마토 김응태 기자] SK E & C will promote 120 billion won from the Namyangsan Fuel Cell Power Generation Project. Headquarters of SK Construction in Jongno-gu, Seoul. SK E & C …
Read More »